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Lower Physical Activity Is Associated
With Higher Intermuscular Adipose
Tissue in People With Type 2 Diabetes
and Peripheral Neuropathy
Lori J. Tuttle, David R. Sinacore, W. Todd Cade, Michael J. Mueller
Background. Increased lipid accumulation in skeletal muscle has been linked to
insulin resistance, impaired muscle performance, and impaired physical function. It
is unclear whether physical activity is associated with lipid content in skeletal muscle,
muscle performance, or overall physical function.
Objective. The purpose of this study was to characterize physical activity levels
(average daily step count) in a sample of people with diabetes and peripheral
neuropathy and to determine the relationship among step count, intermuscular
adipose tissue volume (IMAT), muscle performance (peak torque, power), and
physical function.
Design. A cross-sectional design was used in this study.
Methods. Twenty-two people with diabetes and peripheral neuropathy (15 men
and 7 women, mean age64.5 years [SD12.7], and mean body mass index
33.2 kg/m2 [SD6.4]) participated. Average daily step count, glycosylated hemoglo-
bin, modified 9-item Physical Performance Test scores, Six-Minute Walk Test dis-
tance, calf intermuscular adipose tissue volume (via magnetic resonance imaging),
and isokinetic dynamometry of the ankle muscles were recorded.
Results. Average daily step count was 7,754 (SD4,678; range3,088–20,079).
Five participants had an average daily step count greater than 10,000. Average IMAT
volume was 84 cm3 (SD88). Greater average daily step count was associated with
younger age (r.39, P.05) and with lower IMAT volume in the calf (r.44,
P.05). Lower IMAT volume was associated with greater muscle performance
(r.45) and physical function (r.43 to .48).
Limitations. The sample in this study may be biased toward people with high
levels of activity because participants were recruited for an exercise study. The
results should not be generalized to people taking fewer than 3,000 steps/day or to
those with a current foot ulcer, peripheral arterial disease, or severe foot deformity
or amputation or who weigh more than 136 kg (300 lb).
Conclusions. Average daily step count was inversely related to IMAT, and IMAT
was inversely related to muscle performance and overall physical function. In addi-
tion, we found that people with diabetes and peripheral neuropathy and without
severe foot deformity appear to be able to take a large number of steps per day.
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Diabetes mellitus is a chronicdisease that affects almost 24million people, with 60% to
70% developing nervous system
impairments, including peripheral
neuropathy.1 Increased physical
activity has been shown to decrease
pain and improve balance, includ-
ing in people with diabetes and
peripheral neuropathy.2 Improved
physical activity is particularly
important for people with diabetes,
not only for improved glucose con-
trol and cardiovascular fitness, but
also because they are twice as likely
as people without diabetes to have
limitations in physical mobility, par-
ticularly in the presence of periph-
eral neuropathy.3
The mechanisms for physical mobil-
ity limitations in people with diabe-
tes are unclear, but previous work
has demonstrated that people with
diabetes, peripheral neuropathy, and
obesity have an increased amount of
adipose tissue (ie, fat) in the muscles
of the lower extremity that is not
noted in their peers and that this
increased intermuscular adipose tis-
sue is associated with poor physical
functional status.4 Intermuscular
adipose tissue (IMAT) is defined as
the visible extracellular adipose tis-
sue that is located beneath the mus-
cle fascia and between and within
muscle groups.5 The mechanism by
which IMAT potentially impairs
physical function is unclear, but
decreased muscle strength (force-
generating capacity) and power have
been associated with an increased
amount of IMAT in the calf and thigh
muscles of people with diabetes and
peripheral neuropathy, thereby sug-
gesting increased IMAT as a mecha-
nism for impaired physical func-
tion.4,6 Intermuscular adipose tissue
has been linked to immobilization in
young adults who are healthy7 and
has been shown to be reduced with
exercise in a population with diabe-
tes and without peripheral neuropa-
thy,8 indicating that physical activity
may be a potent modifier of IMAT
content in skeletal muscle. Intermus-
cular adipose tissue also has been
shown to be higher in the affected
limb in people with chronic stroke9
and spinal cord injury10 and those
with rotator cuff injury with nerve
involvement,11 indicating that nerve
dysfunction (such as peripheral neu-
ropathy) could affect IMAT. In addi-
tion, IMAT has been associated with
insulin resistance,12 suggesting that
it may contribute to or worsen the
metabolic impairments of skeletal
muscle that accompany diabetes. It
is important, therefore, to determine
whether IMAT is influenced by phys-
ical activity, specifically walking, and
if so, whether increases in physical
activity are associated with greater
muscle performance, glucose con-
trol, and physical function in people
with diabetes mellitus and periph-
eral neuropathy.
The purpose of this study was to
characterize activity levels (average
daily step count) in people with dia-
betes and peripheral neuropathy and
to determine the relationship
between activity level and IMAT vol-
ume in the calf, calf muscle volume,
muscle performance, physical func-
tion, and glucose control. The Amer-
ican Diabetes Association recom-
mends that people take 10,000
steps/day,13 but we hypothesized
that people with diabetes and
peripheral neuropathy would take
approximately 5,000 steps/day
based on prior observations and
reports.14–16 We hypothesized that
higher average daily step count
would be associated with lower
IMAT volume, larger muscle volume,
improved glucose control (lower gly-
cosylated hemoglobin [HbA1c] lev-




Twenty-two people with type 2 dia-
betes and peripheral neuropathy (15
men and 7 women, mean age 64.5
years [SD12.7], and mean body
mass index [BMI]33.2 kg/m2 [6.4])
were recruited for this study as part
of a larger study involving exercise
for people with diabetes and periph-
eral neuropathy from the Washing-
ton University School of Medicine
Diabetes Clinic and from diabetes
clinics in the surrounding St Louis
area. Participants were excluded if
they weighed more than 136 kg (300
lb) (equipment weight limit), had a
history of severe foot deformity or
amputation, or had any comorbidity
or medications that would interfere
with exercise (eg, severe rheumatoid
arthritis, peripheral arterial disease
[absent pulses], dialysis, current can-
cer treatment). Participants were
excluded if they had a current foot
ulcer; 2 of the 22 participants had a
history of a previous foot ulcer that
had been healed for at least 6




of peripheral neuropathy was deter-
mined based on an inability to feel
the 5.07 Semmes-Weinstein mono-
filament on at least 1 point on the
plantar surface of the foot and on a
vibration perception threshold of
greater than 25 V as measured with a
biothesiometer.16,17
Activity monitoring. For the pur-
poses of this study, “activity level”
refers specifically to average daily
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Watch activity monitor.* Participants
were given an activity monitor and
were instructed to wear the monitor
around their ankle during all waking
hours. The participants were given
the monitor for at least 9 consecutive
days, calculating an average of 7
days. The first and last days of wear
were excluded from the analysis
because a full 24 hours would not be
recorded. For a day to be included,
the monitor had to be worn for at
least 8 hours, and at least 1 weekend
day was included in the 7-day aver-
age. The device records strides per
day, and steps per day were calcu-
lated by multiplying strides by 2 (1
stride equals 2 steps). Results of
validity tests performed in our labo-
ratory indicate a mean absolute error
of 1.1% (SD3.1%) for participants
who were obese but otherwise
healthy and 1.8% (SD2.4%) for par-
ticipants with diabetes mellitus and
peripheral neuropathy.16
Six-Minute Walk Test. All partici-
pants performed the Six-Minute
Walk Test (6MWT)18 as a measure of
physical function and walking endur-
ance, which was validated previ-
ously in adults who were obese.19
The participants walked back and
forth in a hallway between 2 cones
that were placed 100 feet† apart. The
participants were told that the goal
was to walk as far as possible in 6
minutes; the test was not repeated.
The 6MWT score was recorded as
total distance walked in feet.
Physical Performance Test. The
modified 9-item Physical Perfor-
mance Test (PPT) was used to assess
physical function in all participants.
The 9-item PPT is designed to mimic
activities of daily living, and scores
have been shown to correlate well
with disability and frailty.20–22 Each
of the items is scored on a scale of 0
to 4 based on the time it takes to
complete the task. Each task is per-
formed twice, and the average time
is used to determine the 0 to 4 score.
A maximum score is 36.
Intermuscular adipose tissue.
Intermuscular adipose tissue vol-
umes were quantified with magnetic
resonance imaging (MRI) on the
right leg of each participant using
previously established methods.4
The MRI scans were performed with
the participant in a supine position
with a Siemens CP extremity coil‡
placed over the right calf muscle.
The MRI measurements were per-
formed with a 3.0-T superconduct-
ing MRI instrument‡ with a pulse
sequence of TE12 milliseconds,
TR1,500 milliseconds, matrix
256  256. Thirty transverse slices
were collected beginning at the joint
space of the knee and proceeding
distally. The slices were 7 mm thick
with no interslice gap, with voxel
size of 0.7  0.7  7 mm. The 15
center consecutive slices were
selected to calculate muscle and
IMAT volumes. Volumes were quan-
tified using a PC workstation and
Analyze Direct software version 9.0,§
which uses voxel brightness to dis-
tinguish between muscle and adi-
pose tissues.5 The subcutaneous adi-
pose tissue was removed from each
image by drawing a line along the
deep fascial plane surrounding the
calf muscle so that only the fat
within and between the muscles
(IMAT) remained. On a subset of 10
participants, intraclass correlation
coefficient (2,1) values of the same
scan by the same observer averaged
.98 when scans were measured at
least 7 days apart.
Ankle dorsiflexion and plantar-
flexion peak torque and power.
Concentric isokinetic ankle dorsi-
flexion and plantar-flexion peak
torque and power as measures of
muscle performance were assessed
using a Biodex Multijoint System 3
* Orthocare Innovations, 840 Research Park-
way, Suite 200, Oklahoma City, OK 73104.
† 1 ft0.3048 m.
‡ Siemens Corp, Citicorp Center, 153 E 53rd
St, New York, NY 10022.
§ Mayo Clinic, 200 First St SW, Rochester, MN
55905.
The Bottom Line
What do we already know about this topic?
Some research indicates that people with diabetes and peripheral
neuropathy are less active and have more potentially harmful intermus-
cular adipose tissue (IMAT) than their peers.
What new information does this study offer?
This study reports that a higher average daily step count is associated with
lower levels of IMAT in people with diabetes and peripheral neuropathy
and that some people with diabetes and peripheral neuropathy are able to
have high average daily step counts.
If you’re a patient, what might these findings mean
for you?
Some people with diabetes and peripheral neuropathy are able to main-
tain high levels of physical activity, which is associated with lower levels
of potentially harmful IMAT.
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Pro isokinetic dynamometer. The
tests were performed at angular
velocities of 60°/s. The average
power at 60°/s was determined by
the time-averaged integrated area
under the curve at the constant
velocity of movement in the avail-
able ankle joint range of motion.4 All
participants were given 3 practice
trials to ensure they were comfort-
able with the test. The mean values
for peak torque and average power
were calculated for 3 trials.
Data Analysis
Statistical analyses were performed
using Systat for Windows, version
13.0.# Pearson correlation coeffi-
cients were used to determine the
association between variables. Multi-
ple regression analysis was per-
formed, with average step count as
the dependent variable and IMAT
volume, age, BMI, HbA1c, duration
of diabetes, muscle performance
(dorsiflexion and plantar-flexion
peak torque and power), and physi-
cal performance (6MWT distance
and PPT score) as the independent
variables. Statistical significance was
set at P.05. Post hoc, the 22 par-
ticipants were divided into 3 groups
based on step count in an effort to
determine whether there were dif-
ferences among people who were
taking more steps than the group
mean (8,000 steps/day), those
who were in our expected range for
step count (5,000–8,000 steps/day),
and those whose step count was
lower than expected (5,000 steps/
day). A 1-way analysis of variance
was performed, with age as a cova-
riate to determine differences in
IMAT volumes that were caused by
group differences in activity level.
Analyses of variance also were per-
formed to determine differences in
IMAT volume, muscle volume, mus-
 Biodex Medical Systems, 20 Ramsay Rd, Shir-
ley, NY 11967.
# Systat Software Inc, 225 W Washington St,
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cle performance, PPT scores, and
6MWT distance based on group dif-
ferences in activity level (Tab. 1).
Statistical significance was set at
P.05.
Results
Average daily step count for these 22
participants with diabetes and
peripheral neuropathy ranged from
3,088 to 20,079, with an average of
7,754 (SD4,678). Participant char-
acteristics are listed in Table 1. In
order to characterize the people
who were more active and those
who were less active, the partici-
pants were categorized into 3 groups
based on average step count
(5,000 steps/day, 5,000–8,000
steps/day, and 8,000 steps/day)
(Tab. 1). The group that was taking
fewer than 5,000 steps/day had 3
times the volume of IMAT in their
calf muscles compared with the
groups that were taking 5,000 to
8,000 steps/day and more than 8,000
steps/day (X157 cm3 [SD127] vs
X53 cm3 [SD27] vs X44 cm3
[SD22], respectively; P.05).
However, the more active group also
was younger than the other 2 groups
(Tab. 1). Therefore, a 1-way analysis
of covariance also was performed,
with IMAT volume as the dependent
variable, step count as the indepen-
dent variable, and age as a covariate.
Results were unchanged, and IMAT
volumes remained significantly dif-
ferent (P.03) among the groups.
A multiple regression analysis was
used to determine the variance in
average step count accounted for by
IMAT volume, age, BMI, HbA1c, dia-
betes duration, muscle performance,
and physical function (Tab. 2). The
IMAT volume accounted for 19% of
the variance in average step count
(P.04). The other independent
variables did not account for a signif-
icant portion of the variance in IMAT
volume in this sample (P .05).
Activity as indicated by average step
count was associated with age
(r.39) and with IMAT volume
(r.44), but average step count
was not associated with glucose con-
trol (as indicated by HbA1c), muscle
Table 2.






IMAT volume .44 .19 .19 .04
Age .51 .26 .07 .19
BMI .53 .28 .02 .51
HbA1c .61 .38 .10 .13
Diabetes duration .61 .38 .00 .84
Muscle performanceb .63 .39 .01 .90
Physical performancec .74 .55 .16 .17
a IMATintermuscular adipose tissue, BMIbody mass index, HbA1cglycosylated hemoglobin.
b Muscle performancedorsiflexion and plantar-flexion peak torque and power.




Variable Steps MVol HbA1c PPT 6MWT IMAT DFPT DFPOW PFPT PFPOW DM DUR VPT
Age .39* .46* .54* .15 .22 .31 .20 .12 .23 .21 .04 .36
Steps .23 .12 .27 .10 .44* .05 .02 .19 .18 .09 .03
MVol .35 .09 .17 .45* .69* .65* .36 .12 .02 .03
HbA1c .18 .04 .11 .20 .15 .12 .05 .22 .39*
PPT .75* .43* .03 .08 .55* .43* .36 .08
6MWT .48* .08 .03 .47* .48* .27 .06
IMAT .06 .02 .45* .29 .05 .16
DFPT .97* .37 .14 .03 .03
DFPOW .28 .02 .00 .10
PFPT .82* .35 .02
PFPOW .43* .08
DM DUR .01
a Stepsaverage daily step count, MVolmuscle volume in the calf, HbA1cglycosylated hemoglobin, PPTmodified 9-item Physical Performance Test
score, 6MWTSix-Minute Walk Test distance, IMATintermuscular adipose tissue volume in the calf, DFPTdorsiflexion peak torque, DFPOWdorsiflexion
power, PFPTplantar-flexion peak torque, PFPOWplantar-flexion power, DM DURduration of time with diabetes, VPTvibration perception threshold
(measure of neuropathy). *Indicates significance at P.05.
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performance, muscle volume, or
physical function (P.05) (Tab. 3).
The IMAT volume was associated
with select indicators of muscle per-
formance (plantar-flexion peak
torque: r.45, P.03) and physi-
cal function (PPT score: r.43,
P.04; 6MWT distance: r.48,
P.02) and with average step count
(r.44, P.04).
Discussion
This study is the first to demonstrate
an inverse relationship between
physical activity levels and IMAT
volume in the calf muscle of people
with diabetes and peripheral
neuropathy. We also have demon-
strated a significant relationship
among increased IMAT volume,
lower muscle performance, and
physical function. This finding is in
agreement with that of previous
investigators who found that
increased IMAT was associated with
lower muscle performance,4,6,12 sug-
gesting that IMAT may be a potential
pathway for intervention to mitigate
the impairments associated with dia-
betes and peripheral neuropathy.
However, these data provide only an
association among these variables
and do not imply causation. More
studies are needed to elucidate the
role of IMAT in these processes. In
addition, these findings lead us to
question whether increasing physi-
cal activity could decrease IMAT vol-
ume and improve physical function
in people with diabetes mellitus and
peripheral neuropathy.
Intermuscular adipose tissue volume
also has been linked to insulin resis-
tance23–26 in people with metabolic
syndrome and in those with frank
diabetes. The exact relationship
between IMAT and insulin resistance
is not yet understood, but there is
some evidence that weight loss27
and exercise28–30 can decrease the
amount of IMAT and improve insulin
sensitivity. It is unknown whether
these same effects on IMAT in
response to exercise and weight loss
would be demonstrated in people
with diabetes and peripheral
neuropathy.
We hypothesized that higher average
daily step count would be associated
with less IMAT volume, larger mus-
cle volume, improved glucose con-
trol, higher muscle performance,
and higher physical function. This
study showed that average daily step
count was inversely correlated with
IMAT volume, but step count was
not correlated with glycemic con-
trol, muscle volume, muscle perfor-
mance, or measures of physical func-
tion. Intermuscular adipose tissue
volume was inversely correlated
with muscle performance (plantar-
flexion peak torque) and with mea-
sures of physical function (PPT score
and 6MWT distance). These findings
suggest that activity could be a
modifiable factor with the potential
to affect muscle morphology (IMAT
volume) and, therefore, improve
physical function. The people who
were the least active had 3 times the
volume of IMAT in the calf as the
people who were most active, on
average (Tab. 1). Physical activity has
been associated with IMAT volume
in a population of young and healthy
individuals,7 but this is the first study
showing that activity was associated
with IMAT volume in a population
with diabetes and peripheral neurop-
athy. These results provide evidence
for a potential way not only to affect
the metabolic disturbance of diabe-
tes but also to improve the func-
tional deficits that have been shown
to occur in people with diabetes and
peripheral neuropathy. Indeed, Mar-
cus et al8 demonstrated that people
with type 2 diabetes were able to
improve performance, decrease fat,
and increase lean tissue in the thigh
after a 16-week exercise program
that included both aerobic and
eccentric exercise training.
Additional studies are needed to
determine whether more-intensive
interventions targeted to increase
activity or muscle strength can
improve muscle and physical func-
tion in people with diabetes and
peripheral neuropathy. Whereas the
relationship between average step
count and IMAT volume was signifi-
cant, there also was great variability
in IMAT volume, particularly in peo-
ple with a lower step count (Figure).
As noted in our multiple regression
analysis, IMAT accounted for only
19% of the variation in step count,
and there are many other factors
that could be contributing to the
Figure.
Average step count versus intermuscular adipose tissue (IMAT) volume.
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variability seen in both IMAT and
step count. More studies are needed
to determine the variety of factors
that affect IMAT volume.
In our previous work,4 we found that
people with diabetes, peripheral
neuropathy, and obesity had a
greater IMAT volume in their calf
muscles than their age-matched
peers who did not have diabetes or
peripheral neuropathy and who
were not obese. In our previous
study, IMAT volume was related to
muscle performance and function.
However, we did not have measures
of activity level in our previous
study. The findings in this study that
IMAT volume was associated with
muscle performance and function
are consistent with our previous
results and expand upon this previ-
ous work to include activity level as
a factor that may influence muscle
performance and physical function.
The results suggest that activity is
associated with muscle morphology
and could potentially be a way to
improve the impaired physical func-
tion that accompanies chronic
diabetes.
Based on previous studies, we
hypothesized that people with dia-
betes and peripheral neuropathy
would be taking approximately
5,000 steps/day.15,16 We hypothe-
sized this because, generally, the
expectation is that people with dia-
betes and peripheral neuropathy are
less active than their peers. How-
ever, the group for this study had an
average daily step count of 7,919,
and there were 5 people with diabe-
tes and peripheral neuropathy who
were taking more than 10,000 steps/
day. The average step counts in
this study are consistent with those
from Maluf and Mueller16; however,
they are significantly higher than
those reported by Armstrong et al.15
Because we were recruiting for an
exercise study, our sample may have
been biased toward people with
high activity levels and limited our
ability to recruit participants who
were less active.
Surprisingly, HbA1C levels were not
associated with activity. This finding
is in conflict with other reports in
the literature indicating that exercise
and increased physical activity will
improve glucose control.31 There are
several potential explanations for
our finding that increased physical
activity was not associated with
improved glucose control. First, the
participants in this study were not
participating in a regular exercise
program; the activity measure is a
measure of regular daily walking
activity. Intensity of exercise is a key
factor in maintaining blood glucose
control, and perhaps normal daily
walking, regardless of total number
of steps, does not reach an intensity
level that is consistent with regulat-
ing blood glucose over the previous
3- to 4-month period that HbA1c
indicates. Also, one limitation of this
study is that we do not have any
information on diet for these partic-
ipants, and it is possible that dietary
habits contributed more to overall
HbA1c values than low-intensity
physical activity in this particular
sample. It also is possible that some
of the participants in this study were
not adherent in taking their daily
medication, which also could
adversely affect HbA1c values.
Although this study provides impor-
tant information about the role of
activity in people with diabetes and
peripheral neuropathy, there are lim-
itations that should be considered.
First, the participants in this study
were all interested in participating in
an exercise study, so it is possible
that our sample was biased toward
those who tend to be more active. It
is unclear whether our results are
generalizable to people who are tak-
ing fewer than 3,000 steps/day. In
addition, we excluded people who
had a current foot ulcer, peripheral
arterial disease, or severe foot defor-
mity or amputation or who weighed
more than 136 kg. Our results should
not be generalized to these popula-
tions. There is evidence that walking
capacity and performance decrease
in the presence of severe foot defor-
mity or amputation.32 Additional
research is needed to clarify the con-
traindications and safety precautions
for a walking program or weight-
bearing exercise program, given
various levels of foot deformity and
impairment. Also, based on these
data, we can only say that step count
and IMAT volumes are associated,
but we cannot specify causation.
In conclusion, physical activity is
associated with IMAT volume, and
IMAT volume is related to muscle
performance and overall physical
function. In addition, we found that
people with diabetes and peripheral
neuropathy, but without severe foot
deformity, appear to be able to take
a large number of steps per day.
More evidence is needed to deter-
mine whether an exercise program
designed to increase step count will
decrease the amount of IMAT vol-
ume and enhance muscle perfor-
mance and physical function.
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